• Home
  • NEW DAY MEDICINE
  • 3 (65) 2024
  • 9 -3 (65) 2024 - Akhmedova Sh.Kh., Rakhimov R.A., Isroilov Kh.T., Lokteva L.M. - EPIDEMIOLOGYCAL ASPECTS OF PAPILLOMAVIRUS INFECTION AMONG THE MALE POPULATION OF TASHKENT CITY

9 -3 (65) 2024 - Akhmedova Sh.Kh., Rakhimov R.A., Isroilov Kh.T., Lokteva L.M. - EPIDEMIOLOGYCAL ASPECTS OF PAPILLOMAVIRUS INFECTION AMONG THE MALE POPULATION OF TASHKENT CITY

EPIDEMIOLOGYCAL ASPECTS OF PAPILLOMAVIRUS INFECTION AMONG THE MALE POPULATION OF TASHKENT CITY

Akhmedova Sh.Kh. The Research Institute of Virology of the Scientific and Practical Medical Center of the Republic of Specialized Epidemiology, Microbiology, Infectious and Parasitic Diseases.

Rakhimov R.A. The Research Institute of Virology of the Scientific and Practical Medical Center of the Republic of Specialized Epidemiology, Microbiology, Infectious and Parasitic Diseases.

Isroilov Kh.T. Republican Center for Specialized Dermatovenerology and Cosmetology of Scientific and Practical Medicine.

Lokteva L.M. The Research Institute of Virology of the Scientific and Practical Medical Center of the Republic of Specialized Epidemiology, Microbiology, Infectious and Parasitic Diseases.

Resume

Human papillomavirus (HPV) is a DNA-encapsulated virus with oncogenic potential and is a widespread and highly variable group of viruses. Both men and women play an active role in the process of spreading the virus, and while men are the source of infection compared to the majority of infected women, less attention has been paid to the study of OPV in men, while the prevention of HPV in women is considered adequate developed.

Keywords: Human papilloma virus, DNA, PSR, highly oncogenic, genotype, men.

First page

41

Last page

45

For citation: Akhmedova Sh.Kh., Rakhimov R.A., Isroilov Kh.T., Lokteva L.M. - EPIDEMIOLOGYCAL ASPECTS OF PAPILLOMAVIRUS INFECTION AMONG THE MALE POPULATION OF TASHKENT CITY//New Day in Medicine 3(65)2024 41-45 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Шарипова И.П., Юлдашова Г.Т., Рахимов Р.А., Суяркулова Д.Т., Гареев Р.Ф., Шарапов С.М., Турабова Н.Р., Ахмедова Ш.Х. Предварительные результаты скрининга женщин на ВПЧ и ранних признаков рака шейки матки // Вестник Ташкентской Медицинской Академии. 2023; 3/2: 131-134.
  2. Anantharaman D, Abedi-Ardekani B, Beachler DC, Gheit T, Olshan AF, Wisniewski K, et al. (2018). "Geographic heterogeneity in the prevalence of human papillomavirus in head and neck cancer". // International Journal of Cancer. 2018; 140(9): 1968–1975.
  3. Anjum F., Zohaib J. (2020). "Oropharyngeal Squamous Cell Carcinoma". Definitions. StatPearls (Updated ed.). Treasure Island (FL): StatPearls Publishing. 2020. doi:10.32388/G6TG1L.
  4. Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K, Azizan A. "Human Papillomavirus Infection and Cervical Cancer: Epidemiology, Screening, and Vaccination-Review of Current Perspectives". // Journal of Oncology. 2019; 3257939. doi:10.1155/2019/3257939.
  5. Chen G., Zheng P., Gao L., Zhao J., Wang Y, Qin W. Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or cervical intraepithelial neoplasia in Henan province, central China. // J. Med. Virol. 2020; 92(12): 3743-9.
  6. Milner DA (2015). Diagnostic Pathology: Infectious Diseases. // Elsevier Health Sciences. 2015; 40. ISBN 9780323400374.
  7. Pahud B.A., Ault K.A. "The Expanded Impact of Human Papillomavirus Vaccine". // Infectious Disease Clinics of North America (Review). 2016; 29(4): 715–24. doi:10.1016/j.idc.2015.07.007.
  8. Viens LJ, Henley SJ, Watson M, Markowitz LE, Thomas CC, Thompson TD, et al. (2016). "Human Papillomavirus-Associated Cancers – United States, 2008–2012". MMWR. // Morbidity and Mortality Weekly Report. 2016; 65(26): 661–6. doi:10.15585/mmwr.mm6526a1.

    file

    download